National Health Investors owns a portfolio of senior housing, skilled nursing and medical office properties, mostly leased on long-term triple-net terms that push maintenance, taxes and insurance onto the operator. That structure, plus a tenant base concentrated in established regional operators, gives the rent stream unusually high visibility and a gross margin near 74%. The near-term story is the 33.8% revenue growth, which reflects acquisitions and rent escalators rather than organic demand alone, so the question for a deeper look is how much of that growth is accretive after funding costs. At 19.2x trailing and 18.1x forward earnings, the stock is priced for steady compounding rather than a re-rating, and a 10.7% ROE says the equity base is not yet earning much above its cost. It is worth a closer look if the balance sheet and tenant coverage hold up under a higher-rate environment; the score of 67/100 suggests the case is solid but not yet compelling.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 18 Oct 2026, 16:04 CEST | Rating | Overvalued | first publication | $66.28 |
| 14 Oct 2026, 00:00 CEST | Fair value | $53.86 | $52.40 | $65.62 |
| 11 Oct 2026, 00:00 CEST | ACCE price target | $65.00 | first publication | $64.85 |
| 9 Oct 2026, 00:00 CEST | Fair value | $52.40 | $53.37 | $63.96 |
| 29 Sept 2026, 00:00 CEST | Fair value | $53.37 | $52.34 | $66.92 |
| 18 Sept 2026, 00:00 CEST | Fair value | $52.34 | $53.05 | $68.16 |
| 15 Sept 2026, 00:00 CEST | Fair value | $53.05 | $53.74 | $70.32 |
| 2 Sept 2026, 00:00 CEST | Fair value | $53.74 | $54.32 | $71.11 |
| 30 Aug 2026, 00:00 CEST | Fair value | $54.32 | $65.86 | $72.03 |
| 5 Aug 2026, 00:00 CEST | Fair value | $65.86 | $67.29 | $74.95 |
Answered from National Health Investors Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| NHI National Health Investors Inc. Common Stock | $67.06 | $54 | 25% above | 18.8x | 10.7% | 81 | 68 |
| PHP.L Primary Health Properties Plc | £0.92 | £1 | 76% above | 15.2x | 8.1% | 76 | 60 |
| LTC LTC Properties Inc. Common Stock | $43.75 | $36 | 21% above | 15.2x | 11.8% | 81 | 83 |
| SBRA Sabra Health Care REIT Inc. Common Stock | $19.56 | - | - | 78.2x | 2.4% | 44 | 45 |
| DHC Diversified Healthcare Trust Common Shares of Beneficial Interest | $7.86 | - | - | - | -15.5% | 26 | 32 |
| HR Healthcare Realty Trust Incorporated Common Stock | $17.95 | $11 | 65% above | - | -1.9% | 47 | 36 |
| MPT Medical Properties Trust Inc. common stock | $2.70 | - | - | - | -0.6% | 50 | 39 |
Where NHI ranks against its sector peers on each metric.